Diarrhea is a common side effect reflecting how GLP-1 agonists affect intestinal motility and fluid balance, but it does not indicate treatment efficacy
GHK-Cu vs DHK-Cu vs AHK-Cu All three peptides possess the histidyl-lysine motif, which serves as the copper-binding core
Notably, at higher doses, weight loss appeared to be continuing at week 48 without a clear plateau
Good candidates for peptides for weight loss generally include people who have: A body mass index (BMI) of 30 or higher A BMI of 27 or higher paired with a weight-related health condition, such as high blood pressure, high cholesterol, or diabetes Ongoing struggles with stubborn belly fat or a slow metabolism Age-related fat gain, particularly common among men in their 30s, 40s, 50s, and beyond A weight-loss plateau despite staying consistent with exercise and a clean diet Weight gain linked to a hormonal imbalance or low testosterone Peptide therapy is not appropriate for everyone, however
Most protocols last 48 weeks, followed by a rest period
